Recent News

Recent Blog Posts

Key Provisions in Distribution Agreements

  • August 11th, 2015

We are often asked about Florida distribution agreements and the most important issues to negotiate/discuss (or, in some situations, compromise or take a hard-line stance upon).  This touches upon a few such areas and what […]

Beer Bill Passes Unanimously

The Senate’s malt beverages bill that includes the legalization of the 64 ounce growler passed the House today with a unanimous vote. Much of the news has focused on the excitement of the new found freedom of […]

Current Investigations

Hyperion Therapeutics
Komlossy Law, P.A. is investigating the Board of Directors of Hyperion Therapeutics, Inc. (“Hyperion” or the “Company”) (NASDAQ: HPTX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Horizon Pharma plc (“Horizon”).  Pursuant to the terms of the proposed transaction, Hyperion shareholders are to receive $46.00 for each share of the Company. This represents only a 7.6% premium based on Hyperion’s March 27, 2015 closing price. The proposed compensation is also well below recent price targets set by industry analysts.

The investigation involves whether the Board of Directors of Hyperion breached its fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Hyperion stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy or Ross Appel via email at eck@komlossylaw.com or raa@komlossylaw.com, respectively, or by telephone toll free at (855) 858-1233.  More information is available at http://komlossylaw.com/hyperion/.

Norcraft Companies
Komlossy Law, P.A. is investigating the Board of Directors of Norcraft Companies, Inc. (“Norcraft” or the “Company”) (NYSE: NCFT) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Fortune Brands Home & Security, Inc. (“Fortune”).  Pursuant to the terms of the proposed transaction, Norcraft shareholders are to receive $25.50 for each share of the Company they own. This represents only an 11.4% premium based on Norcraft’s March 27, 2015 closing price.

The investigation involves whether the Board of Directors of Norcraft breached its fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Norcraft stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

SFX Entertainment
Komlossy Law, P.A. is investigating the Board of Directors of SFX Entertainment, Inc. (“SFX” or the “Company”) (NASDAQ: SFXE) for possible breaches of fiduciary duty and other violations of state law in connection with a proposal from Robert F.X. Sillerman, the Company’s Chief Executive Officer and Executive Chairman of the Board of Directors, to acquire all of the outstanding shares of common stock of the company not already owned by him for $4.75 per share in cash. Sillerman owns nearly 40% of the outstanding common stock of SFX Entertainment.

The investigation relates to whether the proposal is fair to the public stockholders of SFX and whether Sillerman is seeking to take advantage of his insider knowledge with respect to the going private proposal. SFX has traded above the offer price for a large majority of its history as a public company.

If you own SFX stock and wish to obtain additional information about your rights as a shareholder at not cost, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

Emulex
Komlossy Law, P.A. is investigating the Board of Directors of Emulex Corporation (“Emulex” or the “Company”) (NYSE: ELX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Avago Technologies Limited (“Avago”).  Pursuant to the terms of the proposed transaction, Emulex shareholders are to receive $8.00 for each share of the Company.

The investigation involves whether the Board of Directors of Emulex breached its fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Emulex stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

Komlossy Law, P.A. represents shareholders in complex litigation, including class action and derivative litigation.  Komlossy Law, P.A. may co-counsel with another firm, or refer a case to another firm.  More information is available upon request.

 

Register for Newsletter

Email info@komlossylaw.com to sign up for our newsletter (Subject: Subscribe).

NewsLetter2Cover